Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Parent Market Analysis: Drug Delivery Market
3.2. Development Of Drug Delivery System
3.3. Market Definition
3.4. Key Drivers
3.4.1. Growing Prevalence Of Respiratory Disease
3.4.2. Advancements In Technology
3.4.3. Rising Geriatric Population
3.5. Key Restraints
3.5.1. Stringent Regulation And Patent Expiry
3.5.2. Increasing Drug Recalls And Drug Failures
3.5.3. Side Effects And Risk Associated With The Drugs

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Regulatory Framework
4.3. Impact Of Covid-19 On Pulmonary Drug Delivery Market
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights

5. Market By Application
5.1. Asthma
5.2. Chronic Obstructive Pulmonary Disease
5.3. Allergic Rhinitis
5.4. Cystic Fibrosis
5.5. Other Applications

6. Market By Distribution Channel
6.1. Hospital Pharmacies
6.2. Retail Pharmacies
6.3. E-Commerce

7. Market By End-User
7.1. Hospitals & Clinics
7.2. Homecare

8. Market By Product
8.1. Metered Dose Inhalers
8.2. Dry Powder Inhalers
8.3. Nebulizer
8.3.1. Pneumatic Nebulizer
8.3.2. Mesh Nebulizer
8.3.3. Ultrasonic Nebulizer
8.4. Accessories

9. Geographical Analysis
9.1. Europe
9.1.1. Germany
9.1.2. The United Kingdom
9.1.3. France
9.1.4. Italy
9.1.5. Russia
9.1.6. Belgium
9.1.7. Poland
9.1.8. Rest Of Europe

10. Company Profiles
10.1. 3M Company
10.2. Actelion Pharmaceuticals Ltd
10.3. Aerogen
10.4. Agilent Technologies Inc
10.5. Astrazeneca Plc
10.6. Boehringer Ingelheim Gmbh
10.7. Clement Clarke International
10.8. Gf Health Products Inc
10.9. Glaxosmithkline Plc
10.10. Koninklijke Philips Nv
10.11. Merck & Co Inc
10.12. Novartis Ag
10.13. Teva Pharmaceutical Industries Limited
10.14. Vectura Group Plc



List of Figures


List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Europe Pulmonary Drug Delivery Market, By Application, In 2019
Figure 6: Europe Pulmonary Drug Delivery Market, By Asthma, 2019-2028 (In $ Million)
Figure 7: Europe Pulmonary Drug Delivery Market, By Chronic Obstructive Pulmonary Disease, 2019-2028 (In $ Million)
Figure 8: Europe Pulmonary Drug Delivery Market, By Allergic Rhinitis, 2019-2028 (In $ Million)
Figure 9: Europe Pulmonary Drug Delivery Market, By Cystic Fibrosis, 2019-2028 (In $ Million)
Figure 10: Europe Pulmonary Drug Delivery Market, By Other Applications, 2019-2028 (In $ Million)
Figure 11: Europe Pulmonary Drug Delivery Market, By Distribution Channel, In 2019
Figure 12: Europe Pulmonary Drug Delivery Market, By Hospital Pharmacies, 2019-2028 (In $ Million)
Figure 13: Europe Pulmonary Drug Delivery Market, By Retail Pharmacies, 2019-2028 (In $ Million)
Figure 14: Europe Pulmonary Drug Delivery Market, By E-Commerce, 2019-2028 (In $ Million)
Figure 15: Europe Pulmonary Drug Delivery Market, By End-User, In 2019
Figure 16: Europe Pulmonary Drug Delivery Market, By Hospitals & Clinics, 2019-2028 (In $ Million)
Figure 17: Europe Pulmonary Drug Delivery Market, By Homecare, 2019-2028 (In $ Million)
Figure 18: Europe Pulmonary Drug Delivery Market, By Product, In 2019
Figure 19: Europe Pulmonary Drug Delivery Market, By Metered Dose Inhalers, 2019-2028 (In $ Million)
Figure 20: Europe Pulmonary Drug Delivery Market, By Dry Powder Inhalers, 2019-2028 (In $ Million)
Figure 21: Europe Pulmonary Drug Delivery Market, By Nebulizer, 2019-2028 (In $ Million)
Figure 22: Europe Nebulizer Market, By Pneumatic Nebulizer, 2019-2028 (In $ Million)
Figure 23: Europe Nebulizer Market, By Mesh Nebulizer, 2019-2028 (In $ Million)
Figure 24: Europe Nebulizer Market, By Ultrasonic Nebulizer, 2019-2028 (In $ Million)
Figure 25: Europe Pulmonary Drug Delivery Market, By Accessories, 2019-2028 (In $ Million)
Figure 26: Europe Pulmonary Drug Delivery Market, Country Outlook, 2019 & 2028 (In %)
Figure 27: Germany Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 28: The United Kingdom Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 29: France Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 30: Italy Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 31: Russia Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 32: Belgium Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 33: Poland Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 34: Rest Of Europe Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - PULMONARY DRUG DELIVERY
TABLE 2: EUROPE PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: EUROPE PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: EUROPE PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: EUROPE PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: EUROPE PULMONARY DRUG DELIVERY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: EUROPE PULMONARY DRUG DELIVERY MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: EUROPE PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: EUROPE PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: EUROPE NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: EUROPE NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: EUROPE PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: EUROPE PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)